Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
EMA safety_alert · 2024-01-26Precautionary measures to address potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines
EMA safety precautionary measures advise restricting valproate use in men prior to conception due to possible risk of neurodevelopmental dis…
-
EMA safety_alert · 2018-02-09PRAC recommends new measures to avoid valproate exposure in pregnancy
The PRAC recommends new measures to prevent valproate exposure during pregnancy due to risks of birth defects and developmental problems in …
-
EMA safety_alert · 2017-07-11EMA seeks views of public during its safety review of valproate
EMA is seeking public input as part of its safety review of valproate, focusing on potential risks and safer use to protect patients, partic…
-
CLINICAL_TRIALS safety_alert · 2016-07-20Clinical Trial Update: TRiptan Use and Serious Vascular Events in Elderly Over 65 Years
A clinical trial update raises safety concerns about triptan use and serious vascular events in adults over 65 with migraine.